Welcome to Drug and Alcohol Treatment
| ||
Drug Treatment Pdf Article
This is a selection made from among articles on Drug Treatment Pdf. For a permanent link to this article, or to bookmark it for future reading, click here.
Drug rehab and alcohol rehabilitation programs
from: There are many rehabilitation programs all over the world. They take into account particular features representing the multitude of personalities of the individuals, the cause of the addiction, as well as the chemical that provoked it. Whatever the professionals may suggest as efficient for a drug rehab, they have all agreed that nothing is more important than the motivation of the person that is going to follow the program. The motivation means an individual will to pass successfully to another stage of your life, a better one.How do you know that you are a drug addict? If your whole life depends on taking or not taking a particular chemical (either legal or illegal drugs), if you wake up in the morning and the first thing that slips into your mind is to get higher, if your whole life is a mess because of your taking drugs, if people around you told you that you are acting abnormal, if you feel isolated by the others because of your decadent life, then it is high time to change something. This something is to check yourself into rehab to get over your addiction. You may choose to become an inpatient or an outpatient, depending on the degree of your addiction. You might need professionals to look after you not only during the period of treatment but also after the treatment, to ensure a successful rehabilitation.
Drug Rehab Programs
There are more types of rehab programs. To choose the best program rehab for you is crucial because your health, your life and even your death may depend on your choice. Here are some alternatives you should think of:
Free standing inpatient drug rehab program short term program for less severe addictions;
Inpatient drug rehab program rehabilitation unit for severe mental and physical disabilities;
Inpatient drug rehab program detoxification unit in general this program takes place on an outpatient basis, but sometimes withdrawal from either drugs or alcohol presupposes extreme measures to prevent relapse. It is important to help patients to change their old habits, and this may happen only through a longer-term disruption from the environment where everything remembers them of the urge to return to the substance of their addiction;
Long term residential drug rehab program is important for those who would relapse easily (youth, chronic addicts, patients with more than one diagnosis etc.).
Detoxification
Detoxification is the first level of a drug rehab. That means to withdraw yourself completely from drug dependency. This level has two stages a physical detox and a psychological detox. The physical detox is achieved by medical specialists who help you to get the substance out of your body, heal the damages the substance has done to you, and attenuate the effects of drug withdrawal over your body. The psychological detox or withdrawal is perhaps even more difficult, takes time, and its failure means certain relapse. You have to achieve counseling meetings which may be organized for individuals, for groups or even for families.
We must not forget that most addictions are based on the psychological problems of the individuals: solitude, unhappiness, hopelessness etc. However, sometimes the cause may be of physical origin: unbearable pain, physical disability etc. Unfortunately relapse is still a major problem for rehab programs, as statistics say, that 75-90 percent of drug addicts have relapsed in one year after the treatment was completed.
About Author
Access some of the best drug rehab treatment resources, together with alcohol and drug rehabilitation programs on RehabCourse.com
You are also invited to visit our new website, Cerebral-Palsy-Med.com and learn about the causes of cerebral palsy
Source: ArticleTrader.com
Drug Treatment Pdf Specific links
Drug Treatment Pdf News
Bayer Submits New Drug Application for Regorafenib for the Treatment of ... - MarketWatch (press release)
Bayer Submits New Drug Application for Regorafenib for the Treatment of ... MarketWatch (press release) WAYNE, NJ, May 23, 2012 /PRNewswire via COMTEX/ -- Bayer HealthCare announced today that it has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) seeking approval for the oral multi-kinase inhibitor regorafenib for the ... |
FDA Advisory Committee Finds Data Support Effectiveness of Tafamidis Meglumine ... - MarketWatch (press release)
FDA Advisory Committee Finds Data Support Effectiveness of Tafamidis Meglumine ... MarketWatch (press release) This recommendation will be taken into consideration by the FDA when making its decision on Pfizer's New Drug Application (NDA) for tafamidis as a treatment for TTR-FAP, a rare and fatal neurodegenerative disease. "TTR-FAP is an irreversible and ... |
FDA Regulation of Antibiotic Use in Agricultural Animals - JURIST
 JURIST | FDA Regulation of Antibiotic Use in Agricultural Animals JURIST Some of these drugs are available over-the-counter (OTC) without a prescription from a veterinarian. Much use of antibiotics in animals is for the treatment, control and prevention of disease (treatment use) but a significant part is for uses such as ... |
Basilea participates in public-private collaboration to tackle antibiotic ... - Reuters
Basilea participates in public-private collaboration to tackle antibiotic ... Reuters Many of the medical advances in recent years, such as chemotherapy for cancer treatment and organ transplantation, depend on effective antibiotics. Despite this need and the continued emergence of bacteria resistant to existing drugs, research has ... |
ONYX PHARMACEUTICALS, INC. : New Drug Application for Regorafenib for the ... - 4-traders
ONYX PHARMACEUTICALS, INC. : New Drug Application for Regorafenib for the ... 4-traders Onyx Pharmaceuticals, Inc. : New Drug Application for Regorafenib for the Treatment of Metastatic Colorectal Cancer Submitted by Bayer Onyx Pharmaceuticals, Inc. today announced that Bayer HealthCare has submitted a New Drug Application (NDA) to the US ... |
AbD Serotec to Launch Panel of HuCAL Anti-Drug Antibodies Supporting the ... - Reuters
AbD Serotec to Launch Panel of HuCAL Anti-Drug Antibodies Supporting the ... Reuters Together with its pharmaceutical partners, MorphoSys has built a therapeutic pipeline of more than 70 human antibody drug candidates for the treatment of cancer, rheumatoid arthritis, and Alzheimer's disease, to name just a few. |
Novartis drug pasireotide LAR shows superior efficacy compared to SandostatinR ... - Reuters
Novartis drug pasireotide LAR shows superior efficacy compared to SandostatinR ... Reuters The study met its primary endpoint, with significantly more patients treated with pasireotide LAR (31.3%) experiencing full control of their disease (defined as the combination of both GH <2.5ยตg/L and age- and sex-matched normalized IGF-1 levels) than ... |
Lil' Marijuana, Coke, Heroin in Your Pocket? Californians Support Making It a ... - LA Weekly (blog)
Lil' Marijuana, Coke, Heroin in Your Pocket? Californians Support Making It a ... LA Weekly (blog) According to a poll this week by Tulchin Research and distributed by the ACLU (PDF), 70 percent of California voters ... ... support a proposal by state Sen. Mark Leno (SB 1506) that would downgrade possession of small amounts of drugs from a felony to ... |
Harvard team cracks code for new drug resistant superbugs - EurekAlert (press release)
Harvard team cracks code for new drug resistant superbugs EurekAlert (press release) The Harvard-wide Antibiotic Resistance Program is using this information to develop new ways to prevent and treat infection by MRSA, VRSA and VRE. The team identified several new compounds that stop MRSA by hitting new targets, and is currently ... |
Auxilium Pharmaceuticals, Inc. and GlaxoSmithKline LLC Enter Into a Co ... - MarketWatch (press release)
Auxilium Pharmaceuticals, Inc. and GlaxoSmithKline LLC Enter Into a Co ... MarketWatch (press release) "Today, GlaxoSmithKline and Auxilium have forged a collaboration to expand our reach to US physicians who treat men with low testosterone and its resulting symptoms, known as hypogonadism, which we believe is a prevalent, but poorly recognized ... |